EGF and breast cancer: Upon examination of the findings, it is apparent that the exposure of BC cells to EGF leads to the cytoplasmic binding of HNMT to HER2, subsequently facilitating the recruitment of γ-secretase components (PS1 or PS2) for the generation of HER2-ICD within the cytoplasm.